PFE 241227 26.00P (PFE241227P26000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

PFE241227P26000

Watchlist

0.01
0.000.00%

15min DelayClose Dec 27 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Pfizer Options Spot-On: On January 10th, 114.74K Contracts Were Traded, With 3.27 Million Open Interest
Moomoo News16:30 ET
Weekly Buzz: CES Came and Brought the Pain? That's Unexpected
Kevin Travers16:21 ET
Wall Street Today: Labor Gains Hurt a Hurting Market
Kevin Travers16:08 ET
BioNTech Positioned For Solid Growth Amid Oncology Transition: Analyst
Benzinga14:54 ET
Express News | FDA: Hospira's Marcaine, Injection, 250 Mg/50 Ml (5 Mg/Ml); Multiple Dose Glass Fliptop Vial Discontinued - Website
Reuters14:49 ET
Arvinas Shares Fall Amid Breast Cancer Drug Trial Update, CCO Departure
MT Newswires14:37 ET

Comments

AusMario838

7 hours ago

green green

Deep Sea

9 hours ago

$Pfizer (PFE.US)$
Pfizer Inc (NYSE:PFE) shares are just "too low to sell," according to Jim Cramer, host of CNBC's "Mad Money Lightning Round."
Hold the stock and let "the dividend do the job," Cramer advises, preferring to wait for "some good news" on the Seagen acquisition.
Pfizer stock is down more than 7% over the past year. With the Covid wave having past, the pharma giant is in talks to extend its collaboration with medical AI start-up firm PostEra to design antibody-drug conjugates.

$Pfizer (PFE.US)$
Pfizer Inc. (NYSE:PFE) today announced positive topline results from its pivotal Phase 3 CREST trial evaluating sasanlimab, an investigational anti-PD-1 monoclonal antibody (mAb), in combination with Bacillus Calmette-Guérin (BCG) as induction therapy with or without maintenance in patients with BCG-naïve, high-risk non-muscle invasive bladder cancer (NMIBC). The study met its primary endpoint of event-free survival (EFS) by investigator assessment, demonstrating a clinically me...

Stock_Drift

Yesterday 03:05

$Pfizer (PFE.US)$

3 Factors That Make Pfizer's Ultra-High-Yield Dividend Safer Than You Might Think